Delivery Order SPE2DB20D1100-SPE2DB23FC3M9
Award Date 6/29/23
Potential Completion Date 6/30/23
Potential Value $6.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $7,189 delivery order to Amerisourcebergen Drug Corporation for 4561501832 GADAVIST 10 MMOL/10 ML VIAL 10ML. The firm fixed price order is being fulfilled from Amerisourcebergen's Conshohocken, Pennsylvania facility through July 17, 2023 in support of Defense Logistics Agency programs. No set aside designation or subcontractors were identified. GADAVIST is understood to be a magnetic resonance contrast agent used in medical imaging procedures, consistent...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.18 to AmerisourceBergen Drug Corp for Gadavist 10 mmol/10 ml vials on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Gadavist is a gadolinium-based contrast agent used in medical imaging procedures, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gadavist 10 mmol/10 mL vials with a ceiling value of $1,501.90. This non-competitive, firm fixed-price delivery order was awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Gadavist is a contrast agent used in medical imaging procedures, reflecting the company's role as a critical...
- The Defense Logistics Agency awarded a $1,978.68 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562056165 Gadavist 1 mmol/ml bulk vials. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver 30 ml vials of Gadavist, a gadolinium-based contrast agent, to a location in Conshohocken, Pennsylvania by September 6, 2023 to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a delivery order valued at $1,704.90 to AmerisourceBergen Drug Corp for Gadavist 1 mmol/ml bulk vials (30 ml) on May 14, 2025, with an ultimate completion date of May 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Gadavist is a gadolinium-based contrast agent used in magnetic resonance imaging procedures...
- The Defense Logistics Agency awarded a $305.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561730790 GADAVIST 7.5 MMOL/7.5 ML VIAL 7.5ML. Performance will take place in Conshohocken, Pennsylvania under the terms of the contract lasting from August 7 to August 8, 2023. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen Drug Corporation will deliver the requested dosage of a magnetic resonance contrast agent to the Defense Logistics...
- The Defense Logistics Agency awarded a $2,686.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Gadavist 15 mmol/15 ml vials, a contrast agent used in medical imaging procedures. The award was issued on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-competitive, non-set-aside delivery order represents a routine procurement of pharmaceutical supplies to support federal medical operations. The work will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $5,607 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561920662 GADAVIST 10 MMOL/10 ML VIAL 10ML. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania by August 24, 2023 in support of the Defense Logistics Agency's medical supply chain requirements. No subcontractors or set aside designations were identified in the award...
- The Defense Logistics Agency awarded a $413 delivery order to Amerisourcebergen Drug Corporation for Gadavist contrast agent vials. Under this firm fixed price contract, Amerisourcebergen will provide 10 millimoles per 10 milliliter vials of Gadavist magnetic resonance contrast agent to support Defense Logistics Agency medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a two day period in late July 2023. No subcontractors or set...
- The Defense Logistics Agency awarded a delivery order valued at $1,674.00 to AmerisourceBergen Drug Corp for Gadavist 15 mmol/15 ml vials on May 30, 2025, with completion expected by June 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor headquartered in Conshohocken, Pennsylvania. The product will be delivered to the same location, supporting federal medical supply requirements. This delivery order falls under...